Literature DB >> 18587650

In vitro evaluation of proniosomes as a drug carrier for flurbiprofen.

Mahmoud Mokhtar Ahmed Ibrahim1, Omaima A Sammour, Mohamed A Hammad, Nagia A Megrab.   

Abstract

The purpose of the present investigation is to formulate and evaluate proniosomal transdermal carrier systems for flurbiprofen. Proniosomes were prepared using various non-ionic surfactants, namely span 20 (Sp 20), span 40 (Sp 40), span 60 (Sp 60) and span 80 (Sp 80) without and with cholesterol at percentages ranging from 0% to 50%. The effect of surfactant type and cholesterol content on drug release was investigated. Drug release was tested by diffusion through cellophane membrane and rabbit skin. Drug release from the prepared systems was compared to that from flurbiprofen suspensions in distilled water and HPMC (hydroxypropylmethylcellulose) gels. In case of Sp 20 and Sp 80, the added amount of cholesterol affected the preparation type to be either proniosomal alcoholic solutions or liquid crystalline gel systems. On the other hand, both Sp 40 and Sp 60 produced gel systems in presence or absence of cholesterol. Microscopic observations showed that either proniosomal solutions or gel formulations immediately converted to niosomal dispersions upon hydration. Due to the skin permeation barrier, rabbit skin showed lower drug diffusion rates compared to cellophane membrane. The proniosomal composition controlled drug diffusion rates to be either faster or slower than the prepared flurbiprofen suspensions in HPMC gels or distilled water, respectively. In conclusion, this study demonstrated the possibility of using proniosomal formulations for transdermal drug delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587650      PMCID: PMC2977035          DOI: 10.1208/s12249-008-9114-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

1.  In vitro skin permeation of estradiol from various proniosome formulations.

Authors:  J Y Fang; S Y Yu; P C Wu; Y B Huang; Y H Tsai
Journal:  Int J Pharm       Date:  2001-03-14       Impact factor: 5.875

2.  Proniosome based transdermal delivery of levonorgestrel for effective contraception.

Authors:  B Vora; A J Khopade; N K Jain
Journal:  J Control Release       Date:  1998-07-31       Impact factor: 9.776

3.  Release studies from lyotropic liquid crystal systems.

Authors:  H G Ibrahim
Journal:  J Pharm Sci       Date:  1989-08       Impact factor: 3.534

4.  Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol.

Authors:  D Papahadjopoulos; K Jacobson; S Nir; T Isac
Journal:  Biochim Biophys Acta       Date:  1973-07-06

5.  Studies on lecithin-cholesterol-water interactions by differential scanning calorimetry and X-ray diffraction.

Authors:  B D Ladbrooke; R M Williams; D Chapman
Journal:  Biochim Biophys Acta       Date:  1968-04-29

6.  Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug.

Authors:  E Larrucea; A Arellano; S Santoyo; P Ygartua
Journal:  Drug Dev Ind Pharm       Date:  2001       Impact factor: 3.225

7.  Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.

Authors:  P Mura; M T Faucci; G Bramanti; P Corti
Journal:  Eur J Pharm Sci       Date:  2000-02       Impact factor: 4.384

8.  Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate.

Authors:  Jaleh Varshosaz; Abbas Pardakhty; Seied Mohsen Hossaini Baharanchi
Journal:  Drug Deliv       Date:  2005 Mar-Apr       Impact factor: 6.419

Review 9.  Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.

Authors:  Biana Godin; Elka Touitou
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

10.  Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug.

Authors:  B D Anderson; R A Conradi
Journal:  J Pharm Sci       Date:  1985-08       Impact factor: 3.534

View more
  8 in total

1.  Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery.

Authors:  Gamal M El Maghraby; Amal A Ahmed; Mohamed A Osman
Journal:  Saudi Pharm J       Date:  2014-05-12       Impact factor: 4.330

2.  Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.

Authors:  Ahmed A Aboelwafa; Doaa Ahmed El-Setouhy; Aliaa Nabil Elmeshad
Journal:  AAPS PharmSciTech       Date:  2010-11-10       Impact factor: 3.246

3.  Formulation and evaluation of proniosomes containing lornoxicam.

Authors:  Jyotsana R Madan; Nitesh P Ghuge; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 4.  Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges.

Authors:  Kevin Ita; Sharon Ashong
Journal:  AAPS PharmSciTech       Date:  2020-01-06       Impact factor: 3.246

5.  Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.

Authors:  Ghada A Abdelbary; Maha M Amin; Mohamed Y Zakaria
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.

Authors:  Rajan Rajabalaya; Guok Leen; Jestin Chellian; Srikumar Chakravarthi; Sheba R David
Journal:  Pharmaceutics       Date:  2016-08-31       Impact factor: 6.321

7.  Formulation and optimization of clotrimazole-loaded proniosomal gel using 3(2) factorial design.

Authors:  Litha Thomas; Vidya Viswanad
Journal:  Sci Pharm       Date:  2012-05-03

8.  Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer.

Authors:  Asha Paul; K M Fathima; Sreeja C Nair
Journal:  Open Med Chem J       Date:  2017-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.